These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34315271)

  • 1. First Randomized Controlled Trial of Hybrid Closed Loop Versus Multiple Daily Injections or Insulin Pump Using Self-Monitoring of Blood Glucose in Free-Living Adults with Type 1 Diabetes Undertaking Exercise.
    Paldus B; Lee MH; Morrison D; Zaharieva DP; Jones H; Obeyesekere V; Lu J; Vogrin S; LaGerche A; McAuley SA; MacIsaac RJ; Jenkins AJ; Ward GM; Colman P; O'Neal DN
    J Diabetes Sci Technol; 2021 Nov; 15(6):1399-1401. PubMed ID: 34315271
    [No Abstract]   [Full Text] [Related]  

  • 2. Insulin pump therapy and glucose control during Ramadan fasting in an adolescent with type 1 diabetes: from an open-loop sensor-augmented pump therapy with predictive low-glucose management to an advanced hybrid closed-loop system.
    Wannes S; Al Qusayer D; El Abed S; Ben Fredj M
    Acta Diabetol; 2023 Jun; 60(6):851-855. PubMed ID: 36811739
    [No Abstract]   [Full Text] [Related]  

  • 3. Exercise habits and glucose management among older adults with type 1 diabetes using insulin pumps.
    Chakrabarti A; Mohammad Alipoor A; Sandra Segaran TR; Fourlanos S; MacIsaac RJ; Colman PG; McAuley SA
    Acta Diabetol; 2022 Jun; 59(6):865-868. PubMed ID: 35233639
    [No Abstract]   [Full Text] [Related]  

  • 4. Behavioral Patterns and Associations with Glucose Control During 12-Week Randomized Free-Living Clinical Trial of Day and Night Hybrid Closed-Loop Insulin Delivery in Adults with Type 1 Diabetes.
    Emami A; Willinska ME; Thabit H; Leelarathna L; Hartnell S; Dellweg S; Benesch C; Mader JK; Holzer M; Kojzar H; Pieber TR; Arnolds S; Evans ML; Hovorka R
    Diabetes Technol Ther; 2017 Jul; 19(7):433-437. PubMed ID: 28463010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous Glucose Monitoring in Patients With Type 1 Diabetes Taking Insulin Injections.
    Davidson MB
    JAMA; 2017 Jan; 317(4):363-364. PubMed ID: 28118435
    [No Abstract]   [Full Text] [Related]  

  • 6. Changes in Ambulatory Glucose Profile in Patients With Type 1 Diabetes Mellitus After Switching From Sensor-Augmented Insulin Pump Therapy to a Do-It-Yourself Artificial Pancreas System: A Retrospective Data Analysis of Real-World Data.
    Müller-Korbsch M; Frühwald L; Kietaibl A
    J Diabetes Sci Technol; 2022 Nov; 16(6):1577-1579. PubMed ID: 35915931
    [No Abstract]   [Full Text] [Related]  

  • 7. Day-and-night glycaemic control with closed-loop insulin delivery versus conventional insulin pump therapy in free-living adults with well controlled type 1 diabetes: an open-label, randomised, crossover study.
    Bally L; Thabit H; Kojzar H; Mader JK; Qerimi-Hyseni J; Hartnell S; Tauschmann M; Allen JM; Wilinska ME; Pieber TR; Evans ML; Hovorka R
    Lancet Diabetes Endocrinol; 2017 Apr; 5(4):261-270. PubMed ID: 28094136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Day-and-Night Hybrid Closed-Loop Insulin Delivery in Adolescents With Type 1 Diabetes: A Free-Living, Randomized Clinical Trial.
    Tauschmann M; Allen JM; Wilinska ME; Thabit H; Stewart Z; Cheng P; Kollman C; Acerini CL; Dunger DB; Hovorka R
    Diabetes Care; 2016 Jul; 39(7):1168-74. PubMed ID: 26740634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hybrid closed-loop glucose control with faster insulin aspart compared with standard insulin aspart in adults with type 1 diabetes: A double-blind, multicentre, multinational, randomized, crossover study.
    Boughton CK; Hartnell S; Thabit H; Poettler T; Herzig D; Wilinska ME; Ashcroft NL; Sibayan J; Cohen N; Calhoun P; Bally L; Mader JK; Evans M; Leelarathna L; Hovorka R
    Diabetes Obes Metab; 2021 Jun; 23(6):1389-1396. PubMed ID: 33606901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Insulin pump therapy and continuous glucose monitoring].
    Schütz-Fuhrmann I; Rami-Merhar B; Fröhlich-Reiterer E; Hofer SE; Tauschmann M; Mader JK; Resl M; Kautzky-Willer A; Winhofer-Stöckl Y; Laimer M; Zlamal-Fortunat S; Weitgasser R
    Wien Klin Wochenschr; 2023 Jan; 135(Suppl 1):53-61. PubMed ID: 37101025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial.
    Haidar A; Legault L; Dallaire M; Alkhateeb A; Coriati A; Messier V; Cheng P; Millette M; Boulet B; Rabasa-Lhoret R
    CMAJ; 2013 Mar; 185(4):297-305. PubMed ID: 23359039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Glucose sensors, insulin pumps and smart pens are growing together - A clinical update to modern diabetes technology].
    Gehr B
    MMW Fortschr Med; 2020 Dec; 162(21-22):69-75. PubMed ID: 33319293
    [No Abstract]   [Full Text] [Related]  

  • 13. Where Do We Stand with Closed-Loop Systems and Their Challenges?
    Jackson M; Castle JR
    Diabetes Technol Ther; 2020 Jul; 22(7):485-491. PubMed ID: 32069100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large Treatment Effects With Automated Insulin Delivery System.
    Slomski A
    JAMA; 2022 Oct; 328(16):1581-1582. PubMed ID: 36282258
    [No Abstract]   [Full Text] [Related]  

  • 15. Fully Closed Loop Glucose Control With a Bihormonal Artificial Pancreas in Adults With Type 1 Diabetes: An Outpatient, Randomized, Crossover Trial.
    Blauw H; Onvlee AJ; Klaassen M; van Bon AC; DeVries JH
    Diabetes Care; 2021 Mar; 44(3):836-838. PubMed ID: 33397767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the CamAPS FX hybrid closed-loop insulin delivery system on sleep traits in older adults with type 1 diabetes.
    Thabit H; Boughton C; Mubita W; Rubio J; Mader JK; Narendran P; Evans M; Leelarathna L; Wilinska ME; Fullwood C; Gregory AM; Hovorka R; Rutter MK
    Diabetes Obes Metab; 2023 Mar; 25(3):889-893. PubMed ID: 36335565
    [No Abstract]   [Full Text] [Related]  

  • 17. Closed-Loop Insulin Delivery Versus Sensor-Augmented Pump Therapy in Older Adults With Type 1 Diabetes (ORACL): A Randomized, Crossover Trial.
    McAuley SA; Trawley S; Vogrin S; Ward GM; Fourlanos S; Grills CA; Lee MH; Alipoor AM; O'Neal DN; O'Regan NA; Sundararajan V; Colman PG; MacIsaac RJ
    Diabetes Care; 2022 Feb; 45(2):381-390. PubMed ID: 34844995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case of an 89-year-old patient with type 1 diabetes whose indices of continuous glucose monitoring were significantly improved using an insulin pump with a hybrid closed-loop mode.
    Tamura Y; Sato M; Araki A
    Geriatr Gerontol Int; 2023 Apr; 23(4):313-314. PubMed ID: 36847575
    [No Abstract]   [Full Text] [Related]  

  • 19. Adjustment of Open-Loop Settings to Improve Closed-Loop Results in Type 1 Diabetes: A Multicenter Randomized Trial.
    Dassau E; Brown SA; Basu A; Pinsker JE; Kudva YC; Gondhalekar R; Patek S; Lv D; Schiavon M; Lee JB; Dalla Man C; Hinshaw L; Castorino K; Mallad A; Dadlani V; McCrady-Spitzer SK; McElwee-Malloy M; Wakeman CA; Bevier WC; Bradley PK; Kovatchev B; Cobelli C; Zisser HC; Doyle FJ
    J Clin Endocrinol Metab; 2015 Oct; 100(10):3878-86. PubMed ID: 26204135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Automated hybrid closed-loop control with a proportional-integral-derivative based system in adolescents and adults with type 1 diabetes: individualizing settings for optimal performance.
    Ly TT; Weinzimer SA; Maahs DM; Sherr JL; Roy A; Grosman B; Cantwell M; Kurtz N; Carria L; Messer L; von Eyben R; Buckingham BA
    Pediatr Diabetes; 2017 Aug; 18(5):348-355. PubMed ID: 27191182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.